Skip to content


Race-Neutral Testing Could Have Given Access to Life-Saving Lung Transplants for More Black Patients

June 23, 2023 – NEW YORK, NY— Race-neutral lung function interpretation could increase access to lung transplants for Black patients with respiratory disease, according to new research published in the Annals of the American Thoracic Society online ahead of print.

In “Race-Specific Interpretation of Spirometry: Impact on the Lung Allocation Score,” lead researcher J. Henry Brems, MD, MBE of the Johns Hopkins School of Medicine, and colleagues investigated how race-specific versus race-neutral equations alter the lung allocation score (LAS) and the priority for lung transplant across races. The lung allocation score determines which patients get priority on the lung transplant listing.

A group of 8,982 patients were selected from the United Network for Organ Sharing database and the LAS calculated for each patient from both a race-specific and race-neutral approach. Dr. Brems noted that “that a race-specific approach to lung function interpretation has the potential to systematically bias care to the disadvantage of Black patients with respiratory disease.”

He added that, “our results support the recent shift in ATS recommendations to use race-neutral equations as a way to advance the equitable care of respiratory disease.” In a press release announcing the American Thoracic Society’s official statement on race, ethnicity and pulmonary function test interpretation, the lead author of the statement noted: “Reviews of clinical algorithms throughout medicine in the past decade have spawned concerns about bias and harm when race is used as a variable and has led to revisions of these algorithms.”

The degree of harm that may result from bias is critical to examine as lives literally hang in the balance. Lung transplantation is a life-saving option for people with end-stage lung disease. Candidates for a transplant are assigned an LAS score, which is based on – among other things – age, oxygen requirement and lung function test results. A high LAS score will give a patient a higher priority on the transplant list.

In this latest study, the researchers found that “Compared to a race-neutral approach, a race-specific approach resulted in a lower LAS for Black patients and higher LAS for white patients, which may have contributed to racially biased allocation of lung transplants.”

As medicine shifts to a race-neutral approach in disease evaluation and management, more studies will be needed to understand the impact on patient care. “We may need to develop alternative or more holistic approaches to replace current threshold-based decisions, which are used for some diagnostic criteria, treatments, referrals, disability benefits, and even employment eligibility for some occupations,” said Dr. Brems.